Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
67 participants
INTERVENTIONAL
2023-05-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This trial enrolls Veteran smokers at high risk for suicide, and assigns them to receive either cessation treatment as usual, or a novel treatment that incorporates standard behavioral cessation treatment with Dialectical Behavior Therapy (DBT), an evidence-based treatment for suicide risk.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Functional Outcomes of Veterans With PTSD and Tobacco Dependence
NCT02576899
Intervention to Increase Intention to Change Alcohol/Tobacco Use in Veterans With Chronic Disease
NCT07039175
Adjunctive Mood Management for Telephone-based Smoking Cessation
NCT02500589
Smoking Cessation CM for Veterans With or at Risk for Cancer
NCT06432985
Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers
NCT01892813
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Dialectical behavior therapy skills group (DBT-SG) is an evidence-based approach to addressing dysregulation of emotion, teaching skills to help manage emotions more effectively. Preliminary empirical work suggests DBT may also be an effective approach to addressing smoking cessation. Difficulty managing negative emotions is a common reason for smoking cessation failure, suggesting that group DBT may be an effective intervention for cessation. Investigators propose to conduct a pilot treatment study with veterans at risk for suicide as an initial step to developing and evaluating the utility of DBT for smoking cessation in subgroups with high levels of emotion dysregulation.
The primary aims of the proposed study are to 1) adapt a 12-week, manualized DBT-based group intervention for smoking cessation (DBT-C); 2) conduct a randomized trial testing whether DBT-C has better smoking cessation outcomes than standard smoking cessation treatment (SCCT); 3) evaluate whether DBT-C participants have greater improvements on measures of emotion regulation, mood and suicidality than those in the SSCT conditions; and 4) examine intervention acceptability and feasibility.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DBT
Standard behavioral cessation intervention adapted to incorporate DBT skills for emotion regulation.
DBT-C
Tobacco cessation treatment adapted for high risk population.
TAU
Standard behavioral cessation intervention.
Treatment as usual
Standard behavioral tobacco cessation treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DBT-C
Tobacco cessation treatment adapted for high risk population.
Treatment as usual
Standard behavioral tobacco cessation treatment.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* multiple indicators of elevated suicide risk in 6 month period
Exclusion Criteria
* unable to attend virtual intervention
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California
OTHER
Veterans Medical Research Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neal M. Doran
Role: PRINCIPAL_INVESTIGATOR
Veterans Medical Research Foundation / VA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Veterans Medical Research Foundation
San Diego, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
101760002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.